{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:30:25Z","timestamp":1791336625871,"version":"4.3.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"vor","delay-in-days":166,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016016","name":"Gilead Sciences Europe Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Iberoamericana de Micolog\u00eda"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.riam.2021.04.003","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T06:17:16Z","timestamp":1623824236000},"page":"91-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Mucormicosis: perspectiva de manejo actual y de futuro"],"prefix":"10.1016","volume":"38","author":[{"given":"Mar\u00eda Teresa","family":"Mart\u00edn G\u00f3mez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Salavert Llet\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.riam.2021.04.003_bib0355","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/myc.12222","article-title":"Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high-risk patients from 1995 to 2011: A comparison of eras immediately before and after the availability of voriconazole and echinocandin-amphotericin B","volume":"57","author":"Abidi","year":"2014","journal-title":"Mycoses."},{"key":"10.1016\/j.riam.2021.04.003_bib0360","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1093\/jac\/dks189","article-title":"Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: Real-life data from a single-centre institutional retrospective observational study","volume":"67","author":"Auberger","year":"2012","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.riam.2021.04.003_bib0365","first-page":"1734","article-title":"Posaconazole-loaded leukocytes as a novel treatment strategy targeting invasive pulmonary aspergillosis","volume":"215","author":"Baistrocchi","year":"2017","journal-title":"J Infect Dis."},{"key":"10.1016\/j.riam.2021.04.003_bib0370","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1469-0691.2012.03976.x","article-title":"Development of a single tube multiplex real-time PCR to detect the most clinically relevant Mucormycetes species","volume":"19","author":"Bernal-Mart\u00ednez","year":"2013","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.riam.2021.04.003_bib0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.37201\/req\/2260.2019","article-title":"Biomarkers of fungal infection: Expert opinion on the current situation","volume":"33","author":"Bouza","year":"2020","journal-title":"Rev Esp Quimioter."},{"key":"10.1016\/j.riam.2021.04.003_bib0380","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1086\/500212","article-title":"Posaconazole is effective as salvage therapy in zygomycosis: A retrospective summary of 91 cases","volume":"42","author":"Van Burik","year":"2006","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.riam.2021.04.003_bib0385","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.riam.2021.04.003_bib0390","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/13693780701639546","article-title":"The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections","volume":"46","author":"Chamilos","year":"2008","journal-title":"Med Mycol."},{"key":"10.1016\/j.riam.2021.04.003_bib0395","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/myc.13187","article-title":"Epidemiology, clinical features, diagnosis and treatment of cerebral mucormycosis in diabetic patients: A systematic review of case reports and case series","volume":"63","author":"Chegini","year":"2020","journal-title":"Mycoses."},{"key":"10.1016\/j.riam.2021.04.003_bib0400","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 3","key":"10.1016\/j.riam.2021.04.003_bib0405","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12371","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.riam.2021.04.003_bib0410","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1211161","article-title":"Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation","volume":"370","author":"Cunha","year":"2014","journal-title":"N Engl J Med."},{"key":"10.1016\/j.riam.2021.04.003_bib0415","doi-asserted-by":"crossref","first-page":"5394","DOI":"10.1182\/blood-2010-04-279307","article-title":"Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity","volume":"116","author":"Cunha","year":"2010","journal-title":"Blood."},{"key":"10.1016\/j.riam.2021.04.003_bib0420","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/jac\/dkg020","article-title":"In vitro susceptibilities of zygomycetes to conventional and new antifungals","volume":"51","author":"Dannaoui","year":"2003","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.riam.2021.04.003_bib0425","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1093\/jac\/dkv198","article-title":"Invasive mould sinusitis in patients with haematological malignancies: A 10 year single-centre study","volume":"70","author":"Davoudi","year":"2015","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.riam.2021.04.003_bib0430","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1128\/AAC.04435-14","article-title":"Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales","volume":"59","author":"Espinel-Ingroff","year":"2015","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.riam.2021.04.003_bib0435","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.idc.2015.10.011","article-title":"Mucormycoses","volume":"30","author":"Farmakiotis","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.riam.2021.04.003_bib0440","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2014.08.006","article-title":"A registry-based study of non-Aspergillus mould infections in recipients of allogeneic haematopoietic cell transplantation","volume":"21","author":"Fox","year":"2015","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.riam.2021.04.003_bib0445","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11908-012-0272-6","article-title":"Rhino-orbital-cerebral mucormycosis","volume":"14","author":"Gamaletsou","year":"2012","journal-title":"Curr Infect Dis Rep."},{"key":"10.1016\/j.riam.2021.04.003_bib0450","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/320767","article-title":"Resolution of rhinocerebral zygomycosis associated with adjuvant administration of granulocyte-macrophage colony-stimulating factor","volume":"32","author":"Garcia-Diaz","year":"2001","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.riam.2021.04.003_bib0455","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw1327","article-title":"Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosis","volume":"5","author":"Gebremariam","year":"2019","journal-title":"Sci Adv."},{"key":"10.1016\/j.riam.2021.04.003_bib0460","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1172\/JCI71349","article-title":"CotH3 mediates fungal invasion of host cells during mucormycosis","volume":"124","author":"Gebremariam","year":"2014","journal-title":"J Clin Invest."},{"key":"10.1016\/j.riam.2021.04.003_bib0465","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/jac\/dkw433","article-title":"Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis","volume":"72","author":"Gebremariam","year":"2017","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.riam.2021.04.003_bib0470","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1473-3099(16)30541-2","article-title":"Nivolumab plus interferon-\u03b3 in the treatment of intractable mucormycosis","volume":"17","author":"Grimaldi","year":"2017","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.riam.2021.04.003_bib0475","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179136","article-title":"Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: Epidemiology and microbiological characterization of the isolates","volume":"12","author":"Guinea","year":"2017","journal-title":"PLoS One."},{"key":"10.1016\/j.riam.2021.04.003_bib0480","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.1128\/AAC.00536-11","article-title":"Mortality in hematologic malignancy and hematopoietic stem cell transplant patients with mucormycosis, 2001 to 2009","volume":"55","author":"Hammond","year":"2011","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.riam.2021.04.003_bib0485","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/myc.12232","article-title":"Host-iron assimilation: Pathogenesis and novel therapies of mucormycosis","volume":"57","author":"Ibrahim","year":"2014","journal-title":"Mycoses."},{"key":"10.1016\/j.riam.2021.04.003_bib0490","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1128\/AAC.01458-07","article-title":"Combination echinocandin-polyene treatment of murine mucormycosis","volume":"52","author":"Ibrahim","year":"2008","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.riam.2021.04.003_bib0495","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mucormycosis: A systematic review and meta-analysis of case reports","volume":"25","author":"Jeong","year":"2019","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.riam.2021.04.003_bib0500","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1469-0691.2005.01170.x","article-title":"Hyperbaric oxygen as an adjunctive treatment for zygomycosis","volume":"11","author":"John","year":"2005","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.riam.2021.04.003_bib0505","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.idc.2006.06.003","article-title":"Invasive zygomycosis: Update on pathogenesis, clinical manifestations, and management","volume":"20","author":"Kontoyiannis","year":"2006","journal-title":"Infect Dis Clin North Am."},{"key":"10.1016\/j.riam.2021.04.003_bib0510","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1182\/blood-2011-03-316430","article-title":"How I treat mucormycosis","volume":"118","author":"Kontoyiannis","year":"2011","journal-title":"Blood."},{"key":"10.1016\/j.riam.2021.04.003_bib0515","doi-asserted-by":"crossref","first-page":"10660","DOI":"10.1073\/pnas.1312789111","article-title":"Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection","volume":"111","author":"Kumaresan","year":"2014","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.riam.2021.04.003_bib0520","doi-asserted-by":"crossref","first-page":"811.e1","DOI":"10.1016\/j.cmi.2016.03.029","article-title":"Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: A propensity score analysis","volume":"22","author":"Kyvernitakis","year":"2016","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.riam.2021.04.003_bib0525","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1086\/589305","article-title":"Caspofungin-mediated \u03b2-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae","volume":"198","author":"Lamaris","year":"2008","journal-title":"J Infect Dis."},{"key":"10.1016\/j.riam.2021.04.003_bib0530","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1128\/JCM.00318-16","article-title":"Role of antifungal susceptibility testing in non-aspergillus invasive mold infections","volume":"54","author":"Lamoth","year":"2016","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.riam.2021.04.003_bib0535","doi-asserted-by":"crossref","first-page":"e01244","DOI":"10.1128\/AAC.01244-19","article-title":"Therapeutic challenges of non-Aspergillus invasive mold infections in immunosuppressed patients","volume":"63","author":"Lamoth","year":"2019","journal-title":"Antimicrob Agents Chemother."},{"issue":"Suppl 1","key":"10.1016\/j.riam.2021.04.003_bib0540","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1093\/cid\/cir880","article-title":"A global analysis of mucormycosis in France: The RetroZygo study (2005-2007)","volume":"54","author":"Lanternier","year":"2012","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.riam.2021.04.003_bib0545","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1093\/jac\/dkv236","article-title":"Prospective pilot study of high-dose (10mg\/kg\/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis","volume":"70","author":"Lanternier","year":"2015","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.riam.2021.04.003_bib0550","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: A single-arm open-label trial and case-control analysis","volume":"16","author":"Marty","year":"2016","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.riam.2021.04.003_bib0555","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/jof6030173","article-title":"Host immune defense upon fungal infections with mucorales: Pathogen-immune cell interactions as drivers of inflammatory responses","volume":"6","author":"Monta\u00f1o","year":"2020","journal-title":"J Fungi (Basel)."},{"key":"10.1016\/j.riam.2021.04.003_bib0560","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00277-013-1867-1","article-title":"Treatment of invasive fungal infections in cancer patients - Updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)","volume":"93","author":"Mousset","year":"2014","journal-title":"Ann Hematol."},{"key":"10.1016\/j.riam.2021.04.003_bib0565","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s00277-005-1055-z","article-title":"Prophylactic and interventional granulocyte transfusions in patients with haematological malignancies and life-threatening infections during neutropenia","volume":"84","author":"Mousset","year":"2005","journal-title":"Ann Hematol."},{"key":"10.1016\/j.riam.2021.04.003_bib0570","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3324\/haematol.2012.083063","article-title":"Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: A report from the SEIFEM and FUNGISCOPE registries","volume":"98","author":"Pagano","year":"2013","journal-title":"Haematologica."},{"key":"10.1016\/j.riam.2021.04.003_bib0575","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2141.2009.07738.x","article-title":"Zygomycosis: Current approaches to management of patients with haematological malignancies","volume":"146","author":"Pagano","year":"2009","journal-title":"Br J Haematol."},{"key":"10.1016\/j.riam.2021.04.003_bib0580","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1179\/joc.2009.21.3.322","article-title":"Zygomycosis in Italy: A survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology)","volume":"21","author":"Pagano","year":"2009","journal-title":"J Chemother."},{"key":"10.1016\/j.riam.2021.04.003_bib0585","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.riam.2014.05.002","article-title":"[Invasive fungal disease due to Scedosporium, Fusarium and mucorales] Spanish","volume":"31","author":"Pem\u00e1n","year":"2014","journal-title":"Rev Iberoam Micol."},{"key":"10.1016\/j.riam.2021.04.003_bib0590","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.riam.2014.07.002","article-title":"[Invasive infection diseases by filamentous fungi] Spanish","volume":"31","author":"Pem\u00e1n","year":"2014","journal-title":"Rev Iberoam Micol."},{"issue":"Suppl 1","key":"10.1016\/j.riam.2021.04.003_bib0595","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis","volume":"54","author":"Petrikkos","year":"2012","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.riam.2021.04.003_bib0600","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.15081.1","article-title":"Recent advances in the understanding and management of mucormycosis","volume":"7","author":"Pilmis","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.riam.2021.04.003_bib0605","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/annonc\/mdt110","article-title":"Granulocyte transfusions in hematologic malignancy patients with invasive pulmonary aspergillosis: Outcomes and complications","volume":"24","author":"Raad","year":"2013","journal-title":"Ann Oncol."},{"key":"10.1016\/j.riam.2021.04.003_bib0610","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1093\/cid\/ciy406","article-title":"Breakthrough fungal infections in patients with leukemia receiving isavuconazole","volume":"67","author":"Rausch","year":"2018","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.riam.2021.04.003_bib0615","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/01.qco.0000433309.21148.f7","article-title":"Intra-abdominal fungal infections","volume":"26","author":"Rebolledo","year":"2013","journal-title":"Curr Opin Infect Dis."},{"key":"10.1016\/j.riam.2021.04.003_bib0620","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1086\/589857","article-title":"Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis","volume":"47","author":"Reed","year":"2008","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.riam.2021.04.003_bib0625","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: A review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.riam.2021.04.003_bib0630","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1128\/AAC.00628-08","article-title":"Posaconazole combined with amphotericin B, an effective therapy for a murine disseminated infection caused by Rhizopus oryzae","volume":"52","author":"Rodr\u00edguez","year":"2008","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.riam.2021.04.003_bib0635","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.riam.2018.09.001","article-title":"The treatment of mucormycosis (zygomycosis) in the 21st century","volume":"35","author":"Ruiz Camps","year":"2018","journal-title":"Rev Iberoam Micol."},{"key":"10.1016\/j.riam.2021.04.003_bib0640","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3109\/13693780903311944","article-title":"Primary treatment of zygomycosis with liposomal amphotericin B: Analysis of 28 cases","volume":"48","author":"Shoham","year":"2010","journal-title":"Med Mycol."},{"key":"10.1016\/j.riam.2021.04.003_bib0645","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/jof4030090","article-title":"Therapy of mucormycosis","volume":"4","author":"Sipsas","year":"2018","journal-title":"J Fungi (Basel)."},{"key":"10.1016\/j.riam.2021.04.003_bib0650","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3324\/haematol.2012.065110","article-title":"Diagnosis and treatment of mucormycosis in patients with hematological malignancies: Guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3)","volume":"98","author":"Skiada","year":"2013","journal-title":"Haematologica."},{"key":"10.1016\/j.riam.2021.04.003_bib0655","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1093\/mmy\/myx101","article-title":"Challenges in the diagnosis and treatment of mucormycosis","volume":"56","author":"Skiada","year":"2018","journal-title":"Med Mycol."},{"key":"10.1016\/j.riam.2021.04.003_bib0660","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/j.1469-0691.2010.03456.x","volume":"17","author":"Skiada","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.riam.2021.04.003_bib0665","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3390\/jof6040265","article-title":"Epidemiology and diagnosis of mucormycosis: An update","volume":"6","author":"Skiada","year":"2020","journal-title":"J Fungi (Basel)."},{"key":"10.1016\/j.riam.2021.04.003_bib0670","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/jac\/dkr375","article-title":"The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: A randomized, double-blinded, placebo-controlled trial","volume":"67","author":"Spellberg","year":"2012","journal-title":"J Antimicrob Chemother."},{"issue":"Suppl 1","key":"10.1016\/j.riam.2021.04.003_bib0675","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1093\/cid\/cir885","article-title":"Combination therapy for mucormycosis: Why, what, and how?","volume":"54","author":"Spellberg","year":"2012","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.riam.2021.04.003_bib0680","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3324\/haematol.2016.152900","article-title":"ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients","volume":"102","author":"Tissot","year":"2017","journal-title":"Haematologica."},{"key":"10.1016\/j.riam.2021.04.003_bib0685","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/13693780701796973","article-title":"Workload and clinical significance of the isolation of zygomycetes in a tertiary general hospital","volume":"46","author":"Torres-Narbona","year":"2008","journal-title":"Med Mycol."},{"key":"10.1016\/j.riam.2021.04.003_bib0690","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/1469-0691.12408","article-title":"Local control of rhino-orbito-cerebral mucormycosis dramatically impacts survival","volume":"20","author":"Vironneau","year":"2014","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.riam.2021.04.003_bib0695","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1056\/NEJMc1300111","article-title":"Mucormycosis after a tornado in Joplin, Missouri","volume":"368","author":"Weddle","year":"2013","journal-title":"N Engl J Med."},{"key":"10.1016\/j.riam.2021.04.003_bib0700","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.riam.2018.04.002","article-title":"Clinical features and outcome in patients with mucormycosis in a tertiary hospital (2012-2016)","volume":"35","author":"Xipell","year":"2018","journal-title":"Rev Iberoam Micol."}],"container-title":["Revista Iberoamericana de Micolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130140621000292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130140621000292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T04:07:58Z","timestamp":1761106078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130140621000292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S1130140621000292"],"URL":"https:\/\/doi.org\/10.1016\/j.riam.2021.04.003","relation":{},"ISSN":["1130-1406"],"issn-type":[{"value":"1130-1406","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mucormicosis: perspectiva de manejo actual y de futuro","name":"articletitle","label":"Article Title"},{"value":"Revista Iberoamericana de Micolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.riam.2021.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Asociaci\u00f3n Espa\u00f1ola de Micolog\u00eda.","name":"copyright","label":"Copyright"}]}}